This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Deep brain stimulation for refractory epilepsy

Authoring team

Deep Brain Stimulation (DBS) is used for selected patients with medically refractory epilepsy for whom surgical resection is considered unsuitable

  • involves electrical stimulation of specific sites within the brain (such as the anterior nucleus of the thalamus), which may suppress abnormal electrical activity associated with seizures
  • DBS for refractory epilepsy is carried out with the patient under local or general anaesthesia. One or more permanent electrodes are inserted into the brain using imaging guidance
    • following satisfactory electrode testing, a pulse generator is implanted under the chest wall and connected by tunnelled wires to the electrodes. The generator usually remains switched 'on'

NICE have stated that "..The evidence on the efficacy of deep brain stimulation (DBS) for refractory epilepsy is limited in both quantity and quality. The evidence on safety shows that there are serious but well-known side effects. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research.."

Reference;


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.